The role of apoptosis in response to photodynamic therapy: What, where, why, and how

Photochemical and Photobiological Sciences

Volumn 1, Issue 1, 2002, Pages 1-21

  Oleinick, Nancy L ^a   Morris, Rachel L ^a   Belichenko, Irina ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOTOSENSITIZING AGENT; PROTEIN BCL 2; PROTEIN P53; AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; CALCIUM ION; CERAMIDE; HEXYLPYROPHEOPHORBIDE; HYPERICIN; HYPOCRELLIN A; HYPOCRELLIN B; LUTETIUM TEXAPHYRIN; MITOCHONDRIAL DNA; PHOTOFRIN; PHTHALOCYANINE DERIVATIVE; PORPHYRIN DERIVATIVE; PROTEIN P21; PROTOPORPHYRIN; PURPURIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; TALAPORFIN; TEMOPORFIN; UNCLASSIFIED DRUG;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; DRUG EFFECT; HUMAN; METABOLISM; MITOCHONDRION; NEOPLASM; PATHOLOGY; PHOTOCHEMOTHERAPY; REVIEW; SIGNAL TRANSDUCTION; BINDING SITE; CALCIUM CELL LEVEL; CANCER THERAPY; CELL CYCLE PARAMETERS; CELL DEATH; CELL KILLING; CHRONOLOGY; DRUG STRUCTURE; ENZYME ACTIVATION; IN VIVO STUDY; MEDICAL RESEARCH; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REGULATORY MECHANISM; TUMOR CELL;

ANIMALS; APOPTOSIS; CASPASES; HUMANS; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; NEOPLASMS; NF-KAPPA B; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036461958     PISSN: 1474905X     EISSN: None     Source Type: Journal    
DOI: 10.1039/b108586g     Document Type: Review

References (216)

1. T. J. Dougherty, Photodynamic therapy, Photochem. Photobiol., 1993, 58, 895-900.
2. S. A. Khan, T. J. Dougherty and T. S. Mang, An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer, Eur. J. Cancer, 1993, 29A, 1686-1690.
3. H. Lui and R. R. Anderson, Photodynamic therapy in dermatology: Recent developments, Dermatol. Clin., 1993, 11, 1-13.
4. H. I. Pass, Photodynamic therapy in oncology: Mechanisms and clinical use, J. Natl. Cancer Inst., 1993, 85, 443-456.
5. F. Sieber, Phototherapy, photochemotherapy, and bone marrow transplanation, J. Hematother., 1993, 2, 43-62.
6. E. Ben-Hur, S. Rywkin, I. Rosenthal, N. E. Geacintov and B. Horowitz, Virus inactivation in red cell concentrates by photosensitization with phthalocyanines: Protection of red cells but not of vesicular stomatitis virus with a water-soluble analog of vitamin E, Transfusion, 1995, 35, 401-406.
7. P. Gonschlor, F. Gerbeuser, M. Fleuchaus, T. Y. Huehns, A. E. Goetz, U. Welsch, R. Sroka, M. Dellian, H. A. Lehr and B. Hofling, Local photodynamic therapy reduces tissue hyperplasia in an experimental restenosis model, Photochem. Photobiol., 1996, 64, 758-763.
8. J. G. Levy and M. Obochi, New applications in photodynamic therapy: Introduction, Photochem. Photobiol., 1996, 64, 737-739.
9. K. B. Trauner and T. Hasan, Photodynamic treatment of rheumatoid and inflammatory arthritis, Photochem. Photobiol., 1996, 64, 740-750.
10. T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng, Photodynamic Therapy: Review, J. Natl. Cancer Inst., 1998, 90, 889-902.
11. K. R. Weishaupt, C. J. Gomer and T. J. Dougherty, Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor, Cancer Res., 1976, 36, 2326-2329.
12. B. Halliwell and J. M. Gutteridge, Oxygen toxicity, oxygen radicals, transition metals and disease, Biochem. J., 1984, 219, 1-14.
13. B. W. Henderson and T. J. Dougherty, How does photodynamic therapy work?, Photochem. Photobiol., 1992, 55, 145-157.
14. J. Moan and K. Berg, Photochemotherapy of cancer: experimental research, Photochem. Photobiol., 1992, 55, 931-948.
15. T. Hasan and J. A. Parrish, Photodynamic therapy of cancer, in Cancer Medicine, 4th edn., Williams & Wilkins, Baltimore, 1997, pp. 739-750.
16. M. Ochsner, Photodynamic therapy: the clinical perspective. Review on applications for control of diverse tumorous and non-tumorous diseases, Arzneim.-Forsch., 1997, 47, 1185-1194.
17. R. Lipson, E. Baldes and A. Olsen, The use of a derivative of hematoporphyrin in tumor detection, JNCI, 1961, 26, 1.
18. C. J. Lightdale, Role of photodynamic therapy in the management of advanced esophageal cancer, Gastrointest. Endosc. Clin. N. Am., 2000, 10, 397-408.
19. C. J. Gomer, Preclinical examination of first and second generation photosensitizers used in photodynamic therapy, Photochem. Photobiol., 1991, 54, 1093-1107.
20. C. M. Allen, W. M. Sharman and J. E. Van Lier, Current status of phthalocyanines in the photodynamic therapy of cancer, J. Porphyrins Phthalocyanines, 2001, 5, 161-169.
21. J. F. Kerr, A. H. Wyllie and A. R. Currie, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer, 1972, 26, 239-257.
22. A. Ashkenazi and V. M. Dixit, Death receptors: signaling and modulation, Science, 1998, 281, 1305-1308.
23. G. Evan and T. Littlewood, A matter of life and cell death, Science, 1998, 281, 1317 1322.
24. G. Kroemer and J. C. Reed, Mitochondrial control of cell death, Nat. Med., 2000, 6, 513-519.
25. J. C. Reed, Mechanisms of apoptosis, Am. J. Pathol., 2000, 157, 1415 1430.
26. R. J. Arceci, Tumor cell survival and resistance to therapy, Curr. Opin. Hematol., 1996, 3, 279-287.
27. H. J. Guchelaar, A. Vermes, I. Vermes and C. Haanen, Apoptosis: molecular mechanisms and implications for cancer chemotherapy, Pharm. World Sci., 1997, 19, 19-125.
28. A. M. Gorman, A. McGowan, C. O'Neill and T. Cotter, Oxidative stress and apoptosis in neurodegeneration, J. Neurol. Sci., 1996, 139, Suppl 45-52.
29. R. Kinscherf, H. P. Deigner and U. Haberkorn, Apoptosis modulators in the therapy of neurodegenerative diseases, Expert Opin. Invest. Drugs, 2000, 9, 747-764.
30. G. Kroemer, B. Dallaporta and M. Resche-Rigon, The mitochondrial death/life regulator in apoptosis and necrosis, Annu. Rev. Physiol., 1998, 60, 619-642.
31. N. L. Oleinick, Apoptosis in response to photodynamic therapy, Photodynamics News, 1998, 6, 8-9.
32. J. M. Adams and S. Cory, The Bcl-2 protein family: arbiters of cell survival, Science, 1998, 281, 1322-1326.
33. D. R. Green and J. C. Reed, Mitochondria and apoptosis, Science, 1998, 281, 1309-1312.
34. N. A. Thornberry and Y. Lazebnik, Caspases: enemies within, Science, 1998, 281, 1312-1316.
35. P. Costantini, E. Jacotot, D. Decaudin and G. Kroemer, Mitochondrion as a novel target of anticancer chemotherapy, J. Natl. Cancer Inst., 2000, 92, 1042-1053.
36. R. A. Gottlieb, Mitochondria: execution central, FEBS Lett., 2000, 482, 6-12.
37. D. R. Green, Apoptotic pathways: paper wraps stone blunts scissors, Cell, 2000, 102, 1-4.
38. Q. Peng, J. Moan and J. M. Nesland, Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy, Ultrastruct. Pathol., 1996, 20, 109-129.
39. N. L. Oleinick and H. H. Evans, The photobiology of photodynamic therapy: Cellular targets and mechanisms, Radiat. Res., 1998, 150, S146-S156.
40. I. J. Macdonald and T. J. Dougherty, Basic principles of photodynamic therapy, J Porphyrins Phthalocyanines, 2001, 105-129.
41. P. Agostinis, Z. Assefa, A. Vantieghem, J. R. Vandenheede, W. Merlevede and P. De Witte, Apoptotic and anti-apoptotic signaling pathways induced by photodynamic therapy with hypericin, Adv. Enzyme Regul., 2000, 40, 157-182.
42. A. C. Moor, Signaling pathways in cell death and survival after photodynamic therapy, J. Photochem. Photobiol., B, 2000, 57, 1-13.
43. D. Granville and D. Hunt, Porphyrin-mediated photosensitization-Taking the apoptosis fast lane, Curr. Opin. Drug Discovery Dev., 2000, 3, 232-243.
44. D. J. Granville, B. M. McManus and D. W. Hunt, Photodynamic therapy: shedding light on the biochemical pathways regulating porphyrin-mediated cell death, Histol. Histopathol., 2001, 16, 309-317.
45. J. D. Robertson and S. Orrenius, Molecular mechanisms of apoptosis induced by cytotoxic chemicals, Crit. Rev. Toxicol., 2000, 30, 609-627.
46. E. Solary, N. Droin, A. Bettaieb, L. Corcos, M. T. Dimanche-Boitrel and C. Garrido, Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies, Leukemia, 2000, 14, 1833-1849.
47. M. Verheij and H. Bartelink, Radiation-induced apoptosis, Cell Tissue Res., 2000, 301, 133-142.
48. L. Zhuang, B. Wang and D. N. Sauder, Molecular mechanism of ultraviolet-induced keratinocyte apoptosis, J. Interferon Cytokine Res., 2000, 20, 445-454.
49. V J. Kidd, J. M. Lahti and T. Teitz, Proteolytic regulation of apoptosis, Semin. Cell Dev. Biol., 2000, 11, 191-201.
50. H. R. Stennicke and G. S. Salvesen, Caspases - controlling intracellular signals by protease zymogen activation, Biochim. Biophys. Acta, 2000, 1477, 299-306.
51. Z.-H. Qin, Y. Wang, K. K. Kikly, E. Sapp, K. B. Kegel, N. Aronin and M. DiFiglia, Pro-caspase-8 is Predominantly Localized in Mitochondria and Released into Cytoplasm upon Apoptotic Stimulation, J. Biol. Chem., 2001, 276, 8079-8086.
52. A. Gross, J. M. McDonnell and S. J. Korsmeyer, BCL-2 family members and the mitochondria in apoptosis, Genes Dev., 1999, 13, 1899-1911.
53. M. Crompton, Mitochondrial intermembrane junctional complexes and their role in cell death, J. Physiol., 2000, 529, Pt 1, 11-21.
54. A. P. Halestrap, E. Doran, J. P. Gillespie and A. O'Toole, Mitochondria and cell death, Biochem. Soc. Trans., 2000, 28, 170-177.
55. Y. Tsujimoto and S. Shimizu, Bcl-2 family: life-or-death switch, FEBS Lett., 2000, 466, 6-10.
56. B. Antonsson and J. C. Martinou, The Bcl-2 protein family, Exp. Cell Res., 2000, 256, 50-57.
57. J. C. Reed, Bcl-2 family proteins, Oncogene, 1998, 17, 3225-3236.
58. B. W. Johnson and L. H. Boise, Bcl-2 and caspase inhibition cooperate to inhibit tumor necrosis factor-alpha-induced cell death in a Bcl-2 cleavage-independent fashion, J. Biol. Chem., 1999, 274, 18552-18558.
59. D. G. Kirsch, A. Doseff, B. N. Chan, D. S. Lim, N. C. de Souza-Pinto, R. Hansford, M. B. Kastan, Y. A. Lazebnik and J. M. Hardwick, Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c, J. Biol. Chem., 1999, 274, 21155-21161.
60. V. V. Stoka, B. Turk, S. L. Schendel, T. H. Kim, T. Cirman, S. J. Snipas, L. M. Ellerby, D. Bredesen, H. Freeze, M. Abrahamson, D. Bromme, S. Krajewski, J. C. Reed, X. M. Yin, V. V. Turk and G. S. Salvesen, Lysosomal protease pathways to apoptosis: cleavage of bid, not Pro-caspases, is the most likely route, J. Biol. Chem., 2001, 276, 3149-3157.
61. M. Lam, M. B. Bhat, G. Nunez, J. Ma and C. W. Distelhorst, Regulation of Bcl-xl channel activity by calcium, J. Biol. Chem., 1998, 273, 17307-17310.
62. D. M. Hockenbery, Z. N. Oltvai, X.-M. Yin, C. L. Milliman and S. J. Korsmeyer, Bcl-2 functions in an antioxidant pathway to prevent apoptosis, Cell, 1993, 75, 241-251.
63. J. C. Reed, Cytochrome c: Can't live with it - can't live without it, Cell, 1997, 91, 559-562.
64. J. Yang, K. Bhalla, C. N. Kim, A. M. Ibrado, T. I. Peng, D. P. Jones and X. Wang, Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked, Science, 1997, 275, 1129-1132.
65. J. M. Brown and B. G. Wouters, Apoptosis, p53, and tumor cell sensitivity to anticancer agents, Cancer Res., 1999, 59, 1391-1399.
66. M. L. Agarwal, M. E. Clay, E. J. Harvey, H. H. Evans, A. R. Antunez and N. L. Oleinick, Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells, Cancer Res., 1991, 51, 5993-5996.
67. X. Y. He, R. A. Sikes, S. Thomsen, L. W. K. Chung and S. L. Jacques, Photodynamic therapy with Photofrin II induces programmed cell death in carcinoma cell lines, Photochem. Photobiol., 1994, 59, 468-473.
68. B. B. Noodt, K. Berg, T. Stokke, Q. Peng and J. M. Nesland, Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX, Br. J. Cancer, 1996, 74, 22-29.
69. E. Ben-Hur, J. Oetjen and B. Horowitz, Silicon phthalocyanine Pc 4 and red light causes apoptosis in HIV infected cells, Photochem. Photobiol., 1997, 65, 456-460.
70. Y. Luo, C. K. Chang and D. Kessel, Rapid initiation of apoptosis by photodynamic therapy, Photochem. Photobiol., 1996, 63, 528-534.
71. Y. Luo and D. Kessel, The phosphatase inhibitor calyculin antagonizes the rapid initiation of apoptosis by photodynamic therapy, Biochem. Biophys. Res. Commun., 1996, 221, 72-76.
72. D. Separovic, J. He and N. L. Oleinick, Ceramide generation in response to photodynamic treatment of L5178Y mouse lymphoma cells, Cancer Res., 1997, 57, 1717-1721.
73. L.-Y. Xue, J. He and N. L. Oleinick, Rapid tyrosine phosphorylation of HS1 in the response of mouse lymphoma L5178Y-R cells to photodynamic treatment sensitized by the phthalocyanine Pc 4, Photochem. Photobiol., 1997, 66, 105-113.
74. D. Kessel and Y. Luo, Cells in cryptophycin-induced cell-cycle arrest are susceptible to apoptosis, Cancer Lett., 2000, 151, 25-29.
75. D. W. Hunt, H. Jiang, D. J. Granville, A. H. Chan, S. Leong and J. G. Levy, Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes, Immunopharmacology, 1999, 41, 31-44.
76. H. Jiang, D. J. Granville, B. M. McManus, J. G. Levy and D. W. Hunt, Selective depletion of a thymocyte subset in vitro with an immunomodulatory photosensitizer, Clin. Immunol., 1999, 91, 178-187.
77. M. Dellinger, Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol, Photochem. Photobiol., 1996, 64, 182-187.
78. B. B. Noodt, G. H. Rodal, M. Wainwright, Q. Peng, R. Horobin, J. M. Nesland and K. Berg, Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells, Int. J. Cancer, 1998, 75, 941-948.
79. I. E. Kochevar, M. C. Lynch, S. Zhuang and C. R. Lambert, Singlet oxygen, but not oxidizing radicals, induces apoptosis in HL-60 cells, Photochem. Photobiol., 2000, 72, 548-553.
80. C. P. Lin, M. C. Lynch and I. E. Kochevar, Reactive oxidizing species produced near the plasma membrane induce apoptosis in bovine aorta endothelial cells, Exp. Cell Res., 2000, 259, 351-359.
81. D. Kessel and Y. Luo, Mitochondrial photodamage and PDT-induced apoptosis, J. Photochem. Photobiol., 1998, 42, 89-95.
82. D. Kessel, Y. Luo, Y. Deng and C. K. Chang, The role of subcellular localization in initiation of apoptosis by photodynamic therapy, Photochem. Photobiol., 1997, 65, 422-426.
83. Y. Luo and D. Kessel, Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine, Photochem. Photobiol., 1997, 66, 479-483.
84. K. W. Woodburn, Q. Fan, D. R. Miles, D. Kessel, Y. Luo and S. W. Young, Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model, Photochem. Photobiol., 1997, 65, 410-415.
85. B. B. Noodt, K. Berg, T. Stokke, Q. Peng and J. M. Nesland, Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light, Br. J. Cancer, 1999, 79, 72 81.
86. D. Kessel and R. D. Poretz, Sites of photodamage induced by photodynamic therapy with a chlorin e6 triacetoxymethyl ester (CAME), Photochem. Photobiol., 2000, 71, 94-96.
87. J. He and N. L. Oleinick, in 5th International Photodynamic Association Meeting, 1995, Vol. 2371, pp. 92-96 SPIE, Amelia Island, Florida.
88. A. Vantieghem, Z. Assefa, P. Vandenabeele, W. Declercq, S. Courtois, J. R. Vandenheede, W. Merlevede, P. de Witte and P. Agostinis, Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis, FEBS Lett., 1998, 440, 19-24.
89. H. R. Kim, Y. Luo, G. Li and D. Kessel, Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection, Cancer Res., 1999, 59, 3429-3432.
90. G. Lavie, C. Kaplinsky, A. Toren, I. Aizman, D. Meruelo, Y. Mazur and M. Mandel, A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy, Br. J. Cancer, 1999, 79, 423-432.
91. J. Dahle, O. Kaalhus, J. Moan and H. Steen, Cooperative effects of photodynamic treatment of cells in microcolonies, Proc. Natl. Acad. Sci. USA, 1997, 94, 1773-1778.
92. J. Dahle, H. B. Steen and J. Moan, The mode of cell death induced by photodynamic treatment depends on cell density, Photochem. Photobiol., 1999, 70, 363-367.
93. J. Dahle, S. Bagdonas, O. Kaalhus, G. Olsen, H. B. Steen and J. Moan, The bystander effect in photodynamic inactivation of cells, Biochim. Biophys. Acta, 2000, 1475, 273-280.
94. J. Dahle, S. O. Mikalsen, E. Rivedal and H. B. Steen, Gap junctional intercellular communication is not a major mediator in the bystander effect in photodynamic treatment of MDCK II cells, Radiat. Res., 2000, 154, 331-341.
95. A. R. Oseroff, D. Ohuoha, G. Ara, D. McAuliffe, J. Foley and L. Cincotta, Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells, Proc. Natl. Acad. Sci. USA, 1986, 83, 9729-9733.
96. D. J. Ball, Y. Luo, D. Kessel, J. Griffiths, S. B. Brown and D. I. Vernon, The induction of apoptosis by a positively charged methylene blue derivative, J. Photochem. Photobiol., B, 1998, 42, 159-163.
97. N. S. Trivedi, H. W. Wang, A. L. Nieminen, N. L. Oleinick and J. A. Izatt, Quantitative analysis of Pc 4 localization in mouse lymphoma (LY-R) cells via double-label confocal fluorescence microscopy, Photochem. Photobiol., 2000, 71, 634-639.
98. M. Lam, N. L. Oleinick and A.-L. Nieminen, Photodynamic Therapy-Induced Apoptosis in Epidermoid Carcinoma Cells: Reactive Oxygen Species and Mitochondrial Inner Membrane Permeabilization, J Biol. Chem., 2001, in the press.
99. B. C. Wilson, M. Olivo and G. Singh, Subcellular localization of Photofrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy, Photochem. Photobiol., 1997, 65, 166-176.
100. A. Verma, J. Nye and S. H. Snyder, Porphyrins are endogenous ligands for the mitochondrial (periphera-type) benzodiazepine receptor, Mol. Pharmacol., 1987, 84, 2256-2260.
101. A. Verma and S. H. Snyder, Characterization of porphyrin interactions with peripheral type benzodiazepine receptors, Mol. Pharmacol., 1988, 34, 800-805.
102. A. Verma, S. L. Facchina, D. J. Hirsch, S.-Y. Song, L. F. Dillahey, J. R. Williams and S. H. Snyder, Photodynamic tumor therapy: Mitochondrial benzodiazepine receptors as a therapeutic target, Mol. Med., 1998, 4, 40-49.
103. J. Morgan, I. J. MacDonald and A. R. Oseroff, The relationship of peripheral benzodiazepine receptor binding and mitochondrial localization to the phototoxicity of pyropheophorbide ethers, Photochem. Photobiol., 1998, 67, 26S.
104. D. Kessel, M. Antolovich and K. M. Smith, The Role of the Peripheral Benzodiazepine Receptor in the Apoptotic Response to Photodynamic Therapy, Photochem. Photobiol., 2001, 74, 346-349.
105. S. L. Ratcliffe and E. K. Matthews, Modification of the photodynamic action of δ-aminolaevulinic acid (ALA) on rat pancreatoma cells by mitochondrial benzodiazepine receptor ligands, Br. J. Cancer, 1995, 71, 300-305.
106. R. L. Morris, M. E. Varnes, M. E. Kenney, Y.-S. Li, M. W. McEnery and N. L. Oleinick, The Mitochondrial Benzodiazepine Receptor in Photodynamic Therapy: Atypical Binding of the Phthalocyanine Photosensitizer Pc 4 and Ligand Action in Apoptosis, Photochem. Photobiol., 2001, submitted.
107. C. Salet, G. Moreno, F. Ricchelli and P. Bernardi, Singlet oxygen produced by photodynamic action causes inactivation of the mitochondrial permeability transition pore, J. Biol. Chem., 1997, 272, 21938-21943.
108. A. S. Belzacq, E. Jacotot, H. L. Vieira, D. Mistro, D. J. Granville, Z. Xie, J. C. Reed, G. Kroemer and C. Brenner, Apoptosis induction by the photosensitizer verteporfin: identification of mitochondrial adenine nucleotide translocator as a critical target, Cancer Res., 2001, 61, 1260-1264.
109. L. Miccoli, A. Beurdeley-Thomas, G. De Pinieux, F. Sureau, S. Oudard, B. Dutrillaux and M. F. Poupon, Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria, Cancer Res., 1998, 58, 5777-5786.
110. M. E. Varnes, S. M. Chiu, L. Y. Xue and N. L. Oleinick, Photodynamic therapy-induced apoptosis in lymphoma cells: Translocation of cytochrome c causes inhibition of respiration as well as caspase activation, Biochem. Biophys. Res. Commun., 1999, 255, 673-679.
111. S. L. Gibson and R. Hilf, Interdependence of fluence, drug dose and oxygen on hematoporphyrin derivative induced photosensitization of tumor mitochondria, Photochem. Photobiol., 1985, 42, 367-373.
112. D. S. Perlin, R. S. Murant, S. L. Gibson and R. Hilf, Effects of photosensitization by hematoporphyrin derivative on mitochondrial adenosine triphosphatase-mediated proton transport and membrane integrity of R3230AC mammary adenocarcinoma, Cancer Res., 1985, 45, 653-658.
113. A. Atlante, G. Moreno, S. Parsarella and C. Salet, Hematoporphyrin derivative (PF II) photosensitization of isolated mitochondria: Impairment of anion translocation, Biochem. Biophys. Res. Commun., 1986, 141, 584-590.
114. G. Singh, W. P. Jeeves, B. C. Wilson and D. Jang, Mitochondrial photosensitization by Photofrin II, Photochem. Photobiol., 1987, 46, 645-649.
115. J. Morgan, W. R. Potter and A. R. Oseroff, Comparison of photodynamic targets in a carcinoma cell line and its mitochondrial DNA-deficient derivative, Photochem. Photobiol., 2000, 71, 747 757.
116. D. J. Granville, C. M. Carthy, H. Jiang, G. C. Shore, B. M. McManus and D. W. C. Hunt, Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy, FEBS Lett., 1998, 437, 5-10.
117. O. Inanami, A. Yoshito, K. Takahashi, W. Hiraoka and M. Kuwabara. Effects of BAPTA-AM and forskolin on apoptosis and cytochrome c release in photosensitized Chinese hamster V79 cells, Photochem. Photobiol., 1999, 70, 650-655.
118. D. Kessel and Y. Luo, Photodynamic therapy: A mitochondrial inducer of apoptosis, Cell Death Differ., 1999, 6, 28-35.
119. D. Kessel and Y. Luo, Intracellular Sites of Photodamage as a Factor in Apoptotic Cell Death, J. Porphyrin Phthalocyanines, 2001, 5, 181-184.
120. D. Kessel, J. A. Caruso and J. J. Reiners, Jr., Potentiation of photodynamic therapy by ursodeoxycholic acid, Cancer Res., 2000, 60, 6985-6988.
121. J. Gagnebin, M. Brunori, M. Otter, L. Juillerat-Jeanneret, P. Monnier and R. Iggo, A photosensitising adenovirus for photodynamic therapy, Gene Ther., 1999, 6, 1742-1750.
122. G. Schatz, Mitochondria: beyond oxidative phosphorylation, Biochim. Biophys. Acta, 1995, 1271, 123-126.
123. K. K. Singh, J. Russell, B. Sigala, Y. Zhang, J. Williams and K. F. Keshav, Mitochondrial DNA determines the cellular response to cancer therapeutic agents, Oncogene, 1999, 18, 6641-6646.
124. D. Kessel and H. H. Sun, Enhanced responsiveness to photodynamic therapy-induced apoptosis after mitochondrial DNA depletion, Photochem. Photobiol., 1999, 70, 937-940.
125. A. D. Munday, A. Sriratana, J. S. Hill, S. B. Kahl and P. Nagley, Mitochondria are the functional intracellular target for a photosensitizing boronated porphyrin, Biochim. Biophys. Acta, 1996, 1311, 1 4.
126. R. Chaloupka, T. Obsil, J. Plasek and F. Sureau, The effect of hypericin and hypocrellin-A on lipid membranes and membrane potential of 3T3 fibroblasts, Biochim. Biophys. Acta, 1999, 1418, 39 47.
127. R. Chaloupka, P. X. Petit, N. Israel and F. Sureau, Over-expression of Bcl-2 does not protect cells from hypericin photo-induced mitochondrial membrane depolarization, but delays subsequent events in the apoptotic pathway, FEBS Lett., 1999, 462, 295-301.
128. A. J. Kowaltowski, J. Turin, G. L. Indig and A. E. Vercesi, Mitochondrial effets of triarylmethane dyes, J. Bioenerg. Biomembr., 1999, 31, 581-590.
129. C. M. Carthy, D. J. Granville, H. Jiang, J. G. Levy, C. M. Rudin, C. B. Thompson, B. M. McManus and D. W. Hunt, Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activity, Lab. Invest., 1999, 79, 953 965.
130. S.-M. Chiu and N. L. Oleinick, Dissociation of mitochondrial depolarization from cytochrome c release during apoptosis induced by photodynamic therapy, Br. J. Cancer, 2001, 84, 1099 1106.
131. S. Chiu, H. H. Evans, M. Lam, A. Nieminen and N. L. Oleinick, Phthalocyanine 4 photodynamic therapy-induced apoptosis of mouse L5178Y-R cells results from a delayed but extensive release of cytochrome c from mitochondria, Cancer Lett., 2001, 165, 51 58.
132. D. J. Granville, B. A. Cassidy, D. O. Ruehlmann, J. C. Choy, C. Brenner, G. Kroemer, C. van Breemen, P. Margaron, D. W. Hunt and B. M. McManus, Mitochondrial release of apoptosis-inducing factor and cytochrome c during smooth muscle cell apoptosis, Am. J. Pathol., 2001, 159, 305 311.
133. D. J. Granville, C. M. Carthy, H. Jiang, J. G. Levy, B. M. McManus, J. Y. Matroule, J. Piette and D. W. Hunt, Nuclear factor-kappaB activation by the photochemotherapeutic agent verteportin, Blood, 2000, 95, 256-262.
134. L.-Y. Xue, S.-M. Chiu and N. L. Oleinick, Photodynamic Therapy-Induced Death of MCF-7 Human Breast Cancer Cells: A Role for Caspase-3 in the Late Steps of Apoptosis but Not for the Critical Lethal Event, Exp. Cell Res., 2001, 263, 145-155.
135. D. J. Granville, J. G. Levy and D. W. C. Hunt, Photodynamic therapy induces caspase-3 activation in HL-60 cells, Cell Death Differ., 1997, 4, 623 628.
136. J. He, C. M. Whitacre, L.-Y. Xue, N. A. Berger and N. L. Oleinick, Protease activation and cleavage of Poly(ADP-ribose) polymerase: An integral part of apoptosis in response to photodynamic treatment, Cancer Res., 1998, 58, 940-946.
137. Z. Assefa, A. Vantieghem, W. Declercq, P. Vandenabeele, J. R. Vandenheede, W. Merlevede, P. de Witte and P. Agostinis, The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin, J. Biol. Chem., 1999, 274, 8788-8796.
138. W. H. Chan, J. S. Yu and S. D. Yang, Apoptotic signalling cascade in photosensitized human epidermal carcinoma A431 cells: involvement of singlet oxygen, c-Jun N-terminal kinase, caspase-3 and p21-activated kinase 2, Biochem. J., 2000, 351, 221-232.
139. R. Z. Renno, F. C. Delori, R. A. Holzer, E. S. Gragoudas and J. W. Miller, Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells, Invest. Ophthalmol. Vis. Sci., 2000, 41, 3963-3971.
140. F. Gad, G. Viau, M. Boushira, R. Bertrand and R. Bissonnette, Photodynamic therapy with 5-aminolevulinic acid induces apoptosis and caspase activation in malignant t cells, J. Cutan. Med. Surg., 2001, 5, 8-13.
141. D. J. Granville, J. R. Shaw, S. Leong, C. M. Carthy, P. Margaron, D. W. Hunt and B. M. McManus, Release of cytochrome c, Bax migration, Bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis, Am. J. Pathol., 1999, 155, 1021 1025.
142. S. Zhuang, M. C. Lynch and I. E. Kochevar, Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells, Exp. Cell Res., 1999, 250, 203-212.
143. N. Ahmad, S. Gupta, D. K. Feyes and H. Mukhtar, Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in human epidermoid carcinoma A431 cells, J. Invest. Dermatol., 2000, 115, 1041-1046.
144. J. He, M. L. Agarwal, H. E. Larkin, L. R. Friedman, L.-Y. Xue and N. L. Oleinick, The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2, Photochem. Photobiol., 1996, 64, 845-852.
145. D. J. Granville, H. Jiang, M. T. An, J. G. Levy, B. M. McManus and D. W. Hunt, Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy, Br. J. Cancer, 1999, 79, 95-100.
146. D. J. Granville, H. Jiang, M. T. An, J. G. Levy, B. M. McManus and D. W. Hunt, Overexpression of Bcl-X(L) prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA, FEBS Lett., 1998, 422, 151-154.
147. W. G. Zhang, L. P. Ma, S. W. Wang, Z. Y. Zhang and G. D. Cao, Antisense bcl-2 retrovirus vector increases the sensitivity of a human gastric adenocarcinoma cell line to photodynamic therapy, Photochem. Photobiol., 1999, 69, 582-586.
148. M. Srivastava, H. Ahmad, S. Gupta and H. Mukhtar, Involvement of Bcl-2 and Bax in photodynamic therapy mediated apoptosis, J. Biol. Chem., 2001, 276, 15481-15488.
149. L.-Y. Xue, S.-M. Chiu and N. L. Oleinick, Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4, Oncogene; 2001, 20, 3420 3427.
150. A. M. Ibrado, Y. Huang, G. Fang, L. Liu and K. Bhalla, Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells, Cancer Res., 1996, 56, 4743 4748.
151. J. Usuda, T. Okunaka, K. Furukawa, T. Tsuchida, Y. Kuroiwa, Y. Ohe, N. Saijo, K. Nishio, C. Konaka and H. Kato, Increased Cytotoxic Effects of Photodynamic Therapy in IL-6 Gene Transfected Cells via Enhanced Apoptosis, Int. J. Cancer, 2001, 93, 475-480.
152. E. H. Cheng, D. G. Kirsch, R. J. Clem, R. Ravi, M. B. Kastan, A. Bedi, K. Ueno and J. M. Hardwick, Conversion of Bcl-2 to a Bax-like death effector by caspases, Science, 1997, 278, 1966-1968.
153. N. Fujita and T. Tsuruo, Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis, Biochem. Biophys. Res. Commun., 1998, 246, 484-488.
154. D. Grandgirard, E. Studer L. Monney, T. Belser, I. Fellay, C. Borner and M. R. Michel, Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2, EMBO J., 1998, 17, 1268-1278.
155. B. Fadeel, Z. Hassan, E. Hellstrom-Lindberg, J. I. Henter, S. Orrenius and B. Zhivotovsky, Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells, Leukemia, 1999, 13, 719 728.
156. G. Tudor, A. Aguilera, D. O. Halverson, N. D. Laing and E. A. Sausville, Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels, Cell Death Differ., 2000, 7, 574-586.
157. D. Kessel and M. Castelli, Evidence that Bcl-2 is the target of three photosensitizers that induce a rapid apoptotic response, Photochem. Photobiol., 2001, 74, 318-322.
158. S. Zhuang, J. T. Demirs and I. E. Kochevar, p38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide, J. Biol. Chem., 2000, 275, 25939-25948.
159. T. Kawaguchi, S. Yamamoto, N. Naka, K. Okishio, S. Atagi, M. Ogawara, S. Hosoe, M. Kawahara and K. Furuse, Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy, Br. J. Cancer, 2000, 82, 418-423.
160. T. J. McGarrity, L. P. Peiffer, D. J. Granville, C. M. Carthy, J. G. Levy, M. Khandelwal and D. W. Hunt, Apoptosis associated with esophageal adenocarcinoma: influence of photodynamic therapy, Cancer Lett., 2001, 163, 33 41.
161. M. I. Koukourakis, L. Corti, J. Skarlatos, A. Giatromanolaki, B. Krammer, S. Blandamura, M. Piazza, T. Verwanger, G. Schnitzhofer, J. Kostandelos and K. Beroukas, Clinical and experimental evidence of Bcl-2 involvement in the response to photodynamic therapy, Anticancer Res., 2001, 21, 663 668.
162. W. G. Kaelin, The p53 gene family, Oncogene, 1999, 18, 7701 7705.
163. M. S. Sheikh and A. J. Fornace, Role of p53 family members in apoptosis, J. Cell Physiol., 2000, 182, 171-181.
164. E. Ben-Hur and T. M. Dubbelman, Cytoplasmic free calcium changes as a trigger mechanism in the response of cells to photosensitization, Photochem. Photobiol., 1993, 58, 890-894.
165. M. L. Agarwal, H. E. Larkin, S. I. A. Zaidi, H. Mukhtar and N. L. Oleinick. Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells, Cancer Res., 1993, 53, 5897-5902.
166. 2+ concentrations related to PDT-induced apoptosis in photosensitized human cancer cells, Cancer Lett., 1998, 128, 205-210.
167. A. Rück, K. Heckelsmiller, R. Kaufmann, N. Grossman, E. Haseroth and N. Akgun, Light-induced apoptosis involves a defined sequence of cytoplasmic and nuclear calcium release in AlPcS4-photosensitized rat bladder RR 1022 epithelial cells, Photochem. Photobiol., 2000, 72, 210-216.
168. D. K. Perry, Ceramide and apoptosis, Biochem. Soc. Trans., 1999, 27, 399 404.
169. D. Separovic, K. J. Mann and N. L. Oleinick, Association of ceramide accumulation with photodynamic treatment-induced cell death, Photochem. Photobiol., 1998, 68, 101-109.
170. D. Separovic, J. J. Pink, N. L. Oleinick, M. Kester, D. A. Boothman, M. McLoughlin, L. A. Pena and A. Haimovitz-Friedman, Niemann-Pick human lymphoblasts are resistant to phthalocyanine 4-photodynamic therapy-induced apoptosis, Biochem. Biophys. Res. Commun., 1999, 258, 506-512.
171. J. Y. Matroule, G. Bonizzi, P. Morliere, N. Paillous, R. Santus, V. Bours and J. Piette, Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway, J. Biol. Chem., 1999, 274, 2988-3000.
172. R. A. Gottlieb, J. Nordberg. E. Skowronski and B. M. Babior, Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification, Proc. Natl. Acad. Sci. USA, 1996, 93, 654-658.
173. R. Zidovetzki, I. W. Sherman, M. Cardenas and D. B. Borchardt, Chloroquine stabilization of phospholipid membranes against diacylglycerol-induced perturbation, Biochem. Pharmacol., 1993, 45, 183-189.
174. B. Nagy, S. M. Chiu and D. Separovic, Fumonisin B1 does not prevent apoptosis in A431 human epidermoid carcinoma cells after photosensitization with a silicon phthalocyanine, J. Photochem. Photobiol. B, 2000, 57, 132-141.
175. W. H. Tolleson, L. H. Couch, W. B. Melchior, G. R. Jenkins, M. Muskhelishvili, L. Muskhelishvili, L. J. McGarrity, O. Domon, S. M. Morris and P. C. Howard, Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion, Int. J. Oncol., 1999, 14, 833-843.
176. B. Nagy, W.-C. Yeh, T. W. Mak, S.-M. Chiu and D. Separovic, FADD Null Mouse Embyonic Fibroblasts Undergo Apoptosis after Photosensitization with the Silicon Phthalocyanine Pc 4, Arch. Biochem. Biophys., 2001, 385, 194-202.
177. I. Yslas, M. G. Alvarez, C. Marty, G. Mori, E. N. Durantini and V. Rivarola, Expression of Fas antigen and apoptosis caused by 5,10,15, 20-tetra(4-methoxyphenyl)porphyrin (TMP) on carcinoma cells: implication for photodynamic therapy, Toxicology, 2000, 149, 69-74.
178. K. Azizuddin, K. Kalka, S. Chiu, N. Ahmad, H. Mukhtar and D. Separovic, Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells, Int. J. Oncol., 2001, 18, 411 415.
179. B. B. Aggarwal, Apoptosis and nuclear factor-kappa B: a tale of association and dissociation, Biochem. Pharmacol., 2000, 60, 1033 1039.
180. V. Bours, M. Bentires-Alj, A. C. Hellin, P. Viatour, P. Robe, S. Delhalle, V. Benoit and M. P. Merville, Nuclear factor-kappa B, cancer, and apoptosis, Biochem. Pharmacol., 2000, 60, 1085 1089.
181. S. W. Ryter and C. J. Gomer, Nuclear factor kappa B binding activity in mouse L1210 cells following photofrin II-mediated photosensitization, Photochem. Photobiol., 1993, 58, 753-756.
182. G. Kick, G. Messer, A. Goetz, G. Plewig and P. Kind, Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-κB DNA binding, Cancer Res., 1995, 55, 2373-2379.
183. B. Piret, S. Legrand-Poels, C. Sappey and J. Piette, NF-kappa B transcription factor and human immunodeficiency virus type 1 (HIV-1) activation by methylene blue photosensitization, Eur. J. Biochem., 1995, 228, 447-455.
184. S. Legrand-Poels, V. Bours, B. Piret, M. Pflaum, B. Epe, B. Rentier and J. Piette, Transcription factor NF-kappa B is activated by photosensitization generating oxidative DNA damages, J. Biol. Chem., 1995, 270, 6925-6934.
185. J. Y. Matroule, A. C. Hellin, P. Morliere, A. S. Fabiano, R. Santus, M. P. Merville and J. Piette, Role of nuclear factor-kappa B in colon cancer cell apoptosis mediated by aminopyropheophorbide photosensitization, Photochem. Photobiol., 1999, 70, 540-548.
186. J.-Y. Matroule, C. M. Carthy, D. J. Granville, O. Jolois, D. W. Hunt and J. Piette, Mechanism of colon cancer apoptosis mediated by pyropheophorbide-a methylester photosensitization, Oncogene, 2001, 20, 4070 4084.
187. T. S. Lewis, P. S. Shapiro and N. G. Ahn, Signal transduction through MAP kinase cascades, Adv. Cancer. Res., 1998, 74, 49 139.
188. X. Wang, J. L. Martindale, Y. Liu and N. J. Holbrook, The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival, Biochem. J., 1998, 333, 291-300.
189. L.-y. Xue, J. He and N. L. Oleinick, Promotion of photodynamic therapy-induced apoptosis by stress kinases, Cell Death Differ., 1999, 6, 855-864.
190. Y. Zhang, Y. Huang, A. K. Rishi, M. S. Sheikh, B. Shroot, U. Reichert, M. Dawson, G. Poirer and J. A. Fontana, Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid, Exp. Cell Res., 1999, 247, 233-240.
191. J.-S. Tao, J. S. Sanghera, S. L. Pelech, G. Wong and J. G. Levy, Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative, J. Cell Biochem., 1996, 271, 27107 27115.
192. L. O. Klotz, C. Fritsch, K. Briviba, N. Tsacmacidis, F. Schliess and H. Sies, Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy, Cancer Res., 1998, 58, 4297 4300.
193. M. E. Burow, C. B. Weldon, L. I. Melnik, B. N. Duong, B. M. Collins-Burow, B. S. Beckman and J. A. McLachlan, PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis, Biochem. Biophys. Res. Commun., 2000, 271, 342-345.
194. A. H. Kim, G. Khursigara, X. Sun, T. F. Franke and M. V. Chao, Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase I, Mol. Cell. Biol., 2001, 21, 893-901.
195. L. Y. Xue, Y. Qiu, J. He, H. J. Kung and N. L. Oleinick, Etk/Bmx, a PH-domain-containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin, Oncogene, 1999, 18, 3391-3398.
196. D. J. Granville, J. G. Levy and D. W. Hunt, Photodynamic treatment with benzoporphyrin derivative monoacid ring A produces protein tyrosine phosphorylation events and DNA fragmentation in murine P815 cells, Photochem. Photobiol., 1998, 67, 358-362.
197. A. M. R. Fisher, K. Danenberg, D. Banerjee, J. R. Bertino, P. Danenberg and C. J. Gomer, Increased photosensitivity in HL60 cells expressing wild-type p53, Photochem. Photobiol., 1997, 66, 265-270.
198. A. M. Fisher, N. Rucker, S. Wong and C. J. Gomer, Differential photosensitivity in wild-type and mutant p53 human colon carcinoma cell lines, J. Photochem. Photobiol., 1998, 42, 104-107.
199. A. M. R. Fisher, A. Ferrario, N. Rucker, S. Zhang and C. J. Gomer, Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function, Cancer Res., 1999, 59, 331 335.
200. W. G. Zhang, X. W. Li, L. P. Ma, S. W. Wang, H. Y. Yang and Z. Y. Zhang, Wild-type p53 protein potentiates phototoxicity of 2-BA-2-DMHA in HT29 cells expressing endogenous mutant p53, Cancer Lett., 1999, 138, 189-195.
201. Z. Tong, G. Singh and A. J. Rainbow, The role of the p53 tumor suppressor in the response of human cells to photofrin-mediated photodynamic therapy, Photochem. Photobiol., 2000, 71, 201 210.
202. S. Gupta, N. Ahmad and H. Mukhtar, Involvement of nitric oxide during phthalocynine (Pc 4)-photodynamic therapy mediated apoptosis. Cancer Res., 1998, 58, 1785-1788.
203. N. Ahmad, D. K. Feyes, R. Agarwal and H. Mukhtar, Photodynamic therapy results in induction of WAF1/CIP1/p2l, leading to cell cycle arrest and apoptosis, Proc. Natl. Acad. Sci. USA, 1998, 95, 6977-6982.
204. N. Ahmad, S. Gupta and H. Mukhtar, Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431, Oncogene, 1999, 18, 1891-1896.
205. K. Kalka, N. Ahmad, T. Criswell, D. Boothman and H. Mukhtar, Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy-mediated apoptosis of tumor cells and ablation of mouse skin tumors, Cancer Res., 2000, 60, 5984-5987.
206. S. Hotta, H. Kashimura, S. Hirai, A. Nakahara, H. Fukutomi, T. Osuga and Y. Uchiyama, Immediate changes in subcellular structures of transplanted tumors following photodynamic and laser hyperthermic therapy, Lasers Surg. Med., 1995, 16, 262-271.
207. T. Yokota, H. Ikeda, T. Inokuchi, K. Sano and T. Koji, Enhanced cell death in NR-S1 tumor by photodynamic therapy: possible involvement of Fas and Fas ligand system, Lasers Surg. Med., 2000, 26, 449-460.
208. C. M. Whitacre, D. K. Feyes, T. Satoh, J. Grossmann, J. W. Mulvihill, H. Mukhtar and N. L. Oleinick, Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice, Clin. Cancer Res., 2000, 6, 2021-2027.
209. V. C. Colussi, D. K. Feyes, J. W. Mulvihill, Y. S. Li, M. E. Kenney, C. A. Elmets, N. L. Oleinick and H. Mukhtar, Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts, Photochem. Photobiol., 1999, 69, 236-241.
210. S. I. A. Zaidi, N. L. Oleinick, M. T. Zaim and H. Mukhtar, Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: Electron microscopic, histopathologic, and biochemical evidence, Photochem. Photobiol., 1993, 58, 771-776.
211. B. W. Engbrecht, C. Menon, A. V. Kachur, S. M. Hahn and D. L. Fraker, Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model, Cancer Res., 1999, 59, 4334-4342.
212. L. Lilge, M. Portnoy and B. C. Wilson, Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue, Br. J. Cancer, 2000, 83, 1110 1117.
213. R. Agarwal, N. J. Korman, R. R. Mohan, D. K. Feyes, S. Jawed, M. T. Zaim, and H. Mukhtar, Apoptosis is an early event during phthalocyanine photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin, Photochem. Photobiol., 1996, 63, 547-552.
214. J. Webber, Y. Luo, R. Crilly, D. Fromm and D. Kessel, An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo, J. Photochem. Photobiol., B. Biol., 1996, 35, 209-211.
215. C. Zhou, C. Shunji, D. Jinsheng, L. Junlin, G. Jori and C. Milanesi, Apoptosis of mouse MS-2 fibrosarcoma cells induced by photodynamic therapy with Zn(II)-phthalocyanine, J. Photochem. Photobiol., B. Biol., 1996, 33, 219-223.
216. A. Hajri, S. Coffy, F. Vallat, S. Evrard, J. Marescaux and M. Aprahamian, Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo, Br. J. Surg., 1999, 86, 899-906.